11-01 :: December 2010 / January 2011

nanotimes

Companies Facts

death or DNA repair) such comprehensive analysis will gain valuable insights into cellular functions of potential drug targets. Financial details of the agree- ment were not disclosed.

Dr. Henrik Daub, CTO at KINAXO commented: “Posttranslational modifications and their regulation are key factors in understanding cellular behavior and molecular drug action. We are delighted to ap- ply our expertise to support AstraZeneca’s research in such highly promising fields of investigation. This collaboration further strengthens KINAXO’s position as a preferred technology partner for global pharma- ceutical companies.” KINAXO Biotechnologies is a privately-held bio- technology company based in Munich/Martinsried, Germany. http://www.kinaxo.com

K

opin Corporation (NASDAQ: KOPN) has acquired all of the outstanding common stock

of Scotland-based Forth Dimension Displays Ltd. (FDD), an industry leading provider of all-digital, ultrahigh-resolution, near-to-eye ferroelectric reflec- tive microdisplays. The purchase price was approxi- mately $11 million in cash plus an earnout provision if certain revenue milestones are reached within one year of the purchase date.

“Our acquisition of FDD opens new market oppor- tunities for Kopin and expands our product offe- rings to our customers,” said Kopin President and Chief Executive Officer Dr. John C.C. Fan. “FDD’s ultrahigh-resolution reflective microdisplay is already used extensively within a variety of applications such as high-performance cinematography, training and simulation, 3D metrology and medical imaging. Its

proprietary Time Domain Imaging (TDI™) technology provides beautiful high-resolution, full-color images that are critical for these high-end applications. Kopin is the leading transmissive microdisplay com- pany in the world, and with this acquisition we will be the only microdisplay manufacturer that can offer complete system solutions with either reflective or transmissive liquid crystal display technologies,” Dr. Fan continued. “We are delighted to welcome the company’s employees to the Kopin family.”

FDD had approximately $6 million of revenue in 2010 and Kopin projects that FDD will be accretive to 2011 earnings. All of FDD’s key employees have agreed to join Kopin. http://www.kopin.com

L

eica Microsystems has effectively matched the Leica TCS SP5 MP multiphoton microscope with

a fully integrated OPO (Optical Parametric Oscillator) solution. The integration of the Coherent Chameleon Compact OPO with the Leica TCS SP5 MP confo- cal and multiphoton microscope allows observation of fast dynamic processes in living cells with deep penetration at high resolution with one integrated microscope system.

Full integration of the OPO within the software control of the multiphoton system greatly facilitates research as it enables the user to precisely adjust the excitation sources as well as all other imaging settings within the same soft ware. This makes the Leica TCS SP5 MP with OPO a powerful tool for in vivo ima- ging.

The Leica TCS SP5 MP with OPO ex tends the choice of excitation wave lengths from formerly up

31